Drug Class
combination basal insulin and GLP-1 receptor agonist
Type
brand
Active Ingredient
lixisenatide
📋Overview
Soliqua is a combination medication that contains insulin glargine and lixisenatide. It is used to help manage blood sugar levels in adults with type 2 diabetes. By combining a long-acting insulin with a glucagon-like peptide-1 (GLP-1) receptor agonist, it addresses multiple aspects of glucose regulation. This medication is typically considered when blood sugar is not adequately controlled with other therapies.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Soliqua
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.